Correction: ODI Pharma AB publishes the annual report for the fiscal year 2022/2023
The correction refers to the completion of the auditor's remark and ODI Pharma's comment which is now included in the press release. The...
Please find below news from ODI Pharma AB. More stock relevant news can be found in the section "Stock Information" on the "INVESTORS" site.
Correction: ODI Pharma AB publishes the annual report for the fiscal year 2022/2023
Rättelse: ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2022/2023
ODI Pharma AB: Publication of interim report report Q1 2023/2024
ODI Pharma AB publishes the annual report for the fiscal year 2022/2023
ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2022/2023
ODI Pharma AB postpones publication of interim report and annual report until November 24, 2023
Notice to Annual General Meeting in ODI Pharma AB (publ)
Kallelse till årsstämma i ODI Pharma AB (publ)
ODI Pharma AB: Publication of year-end report for the fiscal year 2022/2023
ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.
ODI Pharma AB receives loan financing of EUR 350,000
ODI Pharma AB: Publication of interim report report Q3 2022/2023
ODI Pharma AB: Publication of half-year report 2022/2023
ODI Pharma receives approval from the Office for Registration of Medicinal Products in Poland
Announcement from the Annual General Meeting in ODI Pharma AB (publ)
Kommuniké från årsstämma i ODI Pharma AB (publ)
ODI Pharma AB: Publication of interim report Q1 2022/2023
ODI Pharma AB publishes the annual report for the fiscal year 2021/2022
ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2021/2022
ODI Pharma AB postpones publication of interim report and annual report until November 25, 2022